Frontiers in Cardiovascular Medicine

Clinical Trial

Published on 23 Sep 2022

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

in Cardio-Oncology

Quentin Jacquinot
Nathalie Meneveau
Antoine Falcoz
Malika Bouhaddi
Pauline Roux
Bruno Degano
Marion Chatot
Elsa Curtit
Laura Mansi
Marie-Justine Paillard

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1000846

5,685 views
19 citations

Original Research

Published on 23 Sep 2022

Which cardiac parameters best predict the cardiovascular outcomes among patients with anti-PD-1 immunotherapy-induced myocardial injury?

in Cardio-Oncology

Xiongjun Peng
Yawen Zheng
Zhaowei Zhu
Na Liu
Shenghua Zhou
Junke Long

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.922095

3,055 views
4 citations

Case Report

Published on 23 Sep 2022

Case report: Evaluation of myocardial microcirculation in patients with breast cancer after anthracycline chemotherapy by using intravoxel incoherent motion imaging

in Cardio-Oncology

Shilan Li
Di Tian
Xin Li
Jia Li
Qingwei Song
Yunlong Xia
Zhiyong Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.900309

3,601 views
2 citations

Review

Published on 23 Sep 2022

Cardiovascular disease and chimeric antigen receptor cellular therapy

in Cardio-Oncology

Anjali Rao
Andrew Stewart
Mahmoud Eljalby
Praveen Ramakrishnan
Larry D. Anderson
Farrukh T. Awan
Alvin Chandra
Srilakshmi Vallabhaneni
Kathleen Zhang
Vlad G. Zaha

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.932347

6,533 views
12 citations

Review

Published on 23 Sep 2022

Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?

in Cardio-Oncology

Sabina Mędrek
Sebastian Szmit

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.984951

4,522 views
11 citations

Mini Review

Published on 21 Sep 2022

Cardiovascular effects of immunosuppression agents

in Cardio-Oncology

Aly Elezaby
Ryan Dexheimer
Karim Sallam

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.981838

17,938 views
70 citations

Original Research

Published on 21 Sep 2022

Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study

in Cardio-Oncology

Hasan Ali Farhan
Israa Fadhil Yaseen
Mohammed Alomar
Daniel Lenihan
Susan Dent
Alexander R. Lyon

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.979631

3,503 views

Review

Published on 20 Sep 2022

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment

in Cardio-Oncology

Sridha Ganesh
Peng Zhong
Xiaoyang Zhou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.997660

4,908 views
13 citations

Original Research

Published on 14 Sep 2022

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity

in Cardio-Oncology

Linda Cucciniello
Ettore Bidoli
Elda Viel
Maria Laura Canale
Lorenzo Gerratana
Chiara Lestuzzi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.960240

3,101 views
6 citations

Original Research

Published on 08 Sep 2022

Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways

in Cardio-Oncology

Vincenzo Quagliariello
Margherita Passariello
Annabella Di Mauro
Ciro Cipullo
Andrea Paccone
Antonio Barbieri
Giuseppe Palma
Antonio Luciano
Simona Buccolo
Irma Bisceglia

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.930797

7,001 views
45 citations

Original Research

Published on 25 Aug 2022

Racial and ethnic characteristics and cancer-specific survival in Primary Malignant Cardiac Tumors

in Cardio-Oncology

Mark M. Aloysius
Sanskriti Shrivastava
Chaitanya Rojulpote
Raza Naseer
Hamza Hanif
Milos Babic
Kenneth Gentilezza
Pranjal K. Boruah
Samir Pancholy

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.961160

2,613 views
5 citations

Review

Published on 23 Aug 2022

Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments

in Cardio-Oncology

Wanli Sun
Juping Xu
Li Wang
Yuchen Jiang
Jingrun Cui
Xin Su
Fan Yang
Li Tian
Zeyu Si
Yanwei Xing

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.946137

6,423 views
10 citations

Review

Published on 22 Aug 2022

Cardiogenic shock among cancer patients

in Cardio-Oncology

Anais Curtiaud
Clement Delmas
Justine Gantzer
Lara Zafrani
Martin Siegemund
Ferhat Meziani
Hamid Merdji

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.932400

8,316 views
5 citations

Case Report

Published on 17 Aug 2022

Case report: Recurrent syncope as initial symptom in a patient with neck lymphoma

in Cardio-Oncology

Yanfang Wu
Deyan Yang
Luxi Sun
Xiqi Xu
Peng Gao
Kangan Cheng
Taibo Chen
Zhongwei Cheng
Yongtai Liu
Quan Fang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.932798

4,635 views
2 citations

Original Research

Published on 16 Aug 2022

Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer

in Cardio-Oncology

Florian Posch
Tobias Niedrist
Theresa Glantschnig
Saskia Firla
Florian Moik
Ewald Kolesnik
Markus Wallner
Nicolas Verheyen
Philipp J. Jost
Andreas Zirlik

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.933428

4,317 views
12 citations

Case Report

Published on 16 Aug 2022

Case report: A primary calcified cardiac mass in right atrium partially obstructs the tricuspid valve in a patient on hemodialysis

in Cardio-Oncology

Hongduan Liu
Xiaokang Tu
Hao Zhang
Chengming Fan
Haoyu Tan
Long Song
Qin Wu
Liming Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.950628

3,046 views
3 citations

Original Research

Published on 12 Aug 2022

Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study

in Cardio-Oncology

Yuwei Zhao
Fen Qin
Qingqi Ji
Wuyan Xia
Ben He

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.922811

2,909 views
4 citations

Case Report

Published on 11 Aug 2022

Genetics and clinical phenotype of Erdheim–Chester disease: A case report of constrictive pericarditis and a systematic review of the literature

in Cardio-Oncology

Lorenzo Bartoli
Francesco Angeli
Andrea Stefanizzi
Michele Fabrizio
Pasquale Paolisso
Luca Bergamaschi
Alessandro Broccoli
Pier Luigi Zinzani
Nazzareno Galiè
Paola Rucci

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.876294

5,687 views
12 citations

Original Research

Published on 09 Aug 2022

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy

in Cardio-Oncology

Wenying Jin
Sen Yang
Chao Yu
Tiangang Zhu
Qian Jiang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.960531

2,521 views
4 citations

Case Report

Published on 09 Aug 2022

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

in Cardio-Oncology

Adrian M. Chye
Ina I. C. Nordman
Aaron L. Sverdlov

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.964324

3,230 views
4 citations

General Commentary

Published on 09 Aug 2022

Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment

in Cardio-Oncology

Avirup Guha
Nickolas Stabellini
Alberto J. Montero

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.962698

2,118 views
2 citations

Review

Published on 03 Aug 2022

Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging

in Cardio-Oncology

Jeremy Jong
James R. Pinney
René R. Sevag Packard

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.919719

6,831 views
19 citations

Case Report

Published on 03 Aug 2022

Case report: Minimally invasive excision of multifocal cardiac papillary fibroelastomas involving right atrium and aortic valve

in Cardio-Oncology

Peng Teng
Peng Hu
Shuai Yuan
Liang Ma

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.908567

2,173 views
4 citations

Case Report

Published on 28 Jul 2022

Case report: Primary cardiac angiosarcoma with multiple metastases

in Cardio-Oncology

Xuan Li
Lan Lan
Huijuan Hu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.941967

4,179 views
20 citations

386 articles

articles

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

Which cardiac parameters best predict the cardiovascular outcomes among patients with anti-PD-1 immunotherapy-induced myocardial injury?

Case report: Evaluation of myocardial microcirculation in patients with breast cancer after anthracycline chemotherapy by using intravoxel incoherent motion imaging

Cardiovascular disease and chimeric antigen receptor cellular therapy

Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?

Cardiovascular effects of immunosuppression agents

Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity

Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways

Racial and ethnic characteristics and cancer-specific survival in Primary Malignant Cardiac Tumors

Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments

Cardiogenic shock among cancer patients

Case report: Recurrent syncope as initial symptom in a patient with neck lymphoma

Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer

Case report: A primary calcified cardiac mass in right atrium partially obstructs the tricuspid valve in a patient on hemodialysis

Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study

Genetics and clinical phenotype of Erdheim–Chester disease: A case report of constrictive pericarditis and a systematic review of the literature

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment

Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging

Case report: Minimally invasive excision of multifocal cardiac papillary fibroelastomas involving right atrium and aortic valve

Case report: Primary cardiac angiosarcoma with multiple metastases